tiprankstipranks
Trending News
More News >
Natera Inc. (NTRA)
:NTRA
US Market
Advertisement

Natera (NTRA) Stock Forecast & Price Target

Compare
1,057 Followers
See the Price Targets and Ratings of:

NTRA Analyst Ratings

Strong Buy
11Ratings
Strong Buy
11 Buy
0 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Natera
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

NTRA Stock 12 Month Forecast

Average Price Target

$201.56
▲(43.85% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Natera in the last 3 months. The average price target is $201.56 with a high forecast of $251.00 and a low forecast of $170.00. The average price target represents a 43.85% change from the last price of $140.12.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"102":"$102","177":"$177","252":"$252","139.5":"$139.5","214.5":"$214.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":251,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$251.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":201.56,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$201.56</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":170,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$170.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[102,139.5,177,214.5,252],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,134.58,143.53538461538463,152.49076923076925,161.44615384615386,170.40153846153848,179.3569230769231,188.31230769230768,197.2676923076923,206.22307692307692,215.17846153846153,224.13384615384615,233.08923076923077,242.04461538461538,{"y":251,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,134.58,139.7323076923077,144.8846153846154,150.03692307692307,155.1892307692308,160.34153846153848,165.49384615384616,170.64615384615385,175.79846153846154,180.95076923076925,186.1030769230769,191.25538461538463,196.40769230769232,{"y":201.56,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,134.58,137.3046153846154,140.0292307692308,142.75384615384615,145.47846153846154,148.20307692307694,150.92769230769233,153.6523076923077,156.37692307692308,159.10153846153847,161.82615384615386,164.55076923076922,167.2753846153846,{"y":170,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":103,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":118.26,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":127.19,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.16,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":169.82,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":158.3,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":176.92,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":155.59,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":140.65,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":151.36,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":160.69,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":160.72,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":134.58,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$251.00Average Price Target$201.56Lowest Price Target$170.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on NTRA
TipRanks AITipRanks
Not Ranked
TipRanks
$153
Hold
9.19%
Upside
Reiterated
07/18/25
Natera's strong financial performance and positive earnings call highlight robust revenue growth and strategic advancements in diagnostics, contributing positively to the stock score. However, technical indicators and valuation concerns, driven by a negative P/E ratio and bearish technical signals, weigh down the overall score.
Craig-Hallum Analyst forecast on NTRA
William BonelloCraig-Hallum
Craig-Hallum
Buy
Reiterated
08/04/25
Natera (NTRA) Receives a Buy from Craig-Hallum
Evercore ISI
$170
Buy
21.32%
Upside
Initiated
07/28/25
Natera (NTRA) Receives a Buy from Evercore ISIEvercore ISI analyst Daniel Markowitz initiates coverage on Natera (NASDAQ: NTRA) with a Outperform rating and a price target of $170.00.
Leerink Partners Analyst forecast on NTRA
Puneet SoudaLeerink Partners
Leerink Partners
Buy
Reiterated
07/24/25
Leerink Partners Reaffirms Their Buy Rating on Natera (NTRA)We are reiterating our confidence in NTRA (a top pick for 2Q25 earnings) in light of the continued weakness (down 7.1% in the last week and 19.1% in the last month, vs. XBI up 0.5% and the last week and up 7.2%, 5.7%, respectively, in the last month). We expect a strong beat on revenue and, more importantly, Signatera volumes to beat cons. (11.3k tests) and our 11.8k est. handily. Investor inbounds have increased with the recent sell-off and point to questions of whether NTRA will raise its OpEx guidance, and as to the emerging competitive entrants in the market. We agree that an OpEx guidance raise is likely given the priority that NTRA has to maintain its lead in the $20B (LP est) MRD market, where it's on track to deliver more than $860M+ in our model this year. Our prior conversations with the mgmt.
RBC Capital Analyst forecast on NTRA
Conor McNamaraRBC Capital
RBC Capital
$251
Buy
79.13%
Upside
Reiterated
06/30/25
RBC Capital Reaffirms Their Buy Rating on Natera (NTRA)
Barclays Analyst forecast on NTRA
Luke SergottBarclays
Barclays
$190
Buy
35.60%
Upside
Reiterated
06/25/25
Barclays Sticks to Their Buy Rating for Natera (NTRA)
Piper Sandler Analyst forecast on NTRA
David WestenbergPiper Sandler
Piper Sandler
$205$210
Buy
49.87%
Upside
Reiterated
05/15/25
Piper Sandler Sticks to Their Buy Rating for Natera (NTRA)
Morgan Stanley Analyst forecast on NTRA
Tejas SavantMorgan Stanley
Morgan Stanley
$185
Buy
32.03%
Upside
Reiterated
05/12/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (NYSE: PFE), Natera (NASDAQ: NTRA) and Regeneron (NASDAQ: REGN)
Canaccord Genuity Analyst forecast on NTRA
Kyle Mikson CFACanaccord Genuity
Canaccord Genuity
$180$195
Buy
39.17%
Upside
Reiterated
05/11/25
Natera's Strong Q1 2025 Performance and Strategic Growth Justify Buy Rating
TD Cowen
$195$200
Buy
42.73%
Upside
Reiterated
05/09/25
Natera's Strong Performance and Growth Potential Justifies Buy Rating
UBS
$211$218
Buy
55.58%
Upside
Reiterated
05/09/25
Natera price target raised to $218 from $211 at UBSNatera price target raised to $218 from $211 at UBS
BTIG
$190$195
Buy
39.17%
Upside
Reiterated
05/09/25
BTIG Reaffirms Their Buy Rating on Natera (NTRA)
Bernstein Analyst forecast on NTRA
Eve BursteinBernstein
Bernstein
$200
Buy
42.73%
Upside
Reiterated
04/15/25
Natera (NTRA) Gets a Buy from Bernstein
Robert W. Baird
$183$188
Buy
34.17%
Upside
Reiterated
02/28/25
Natera price target raised to $188 from $183 at BairdNatera price target raised to $188 from $183 at Baird
Jefferies
$195
Buy
39.17%
Upside
Reiterated
02/28/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Natera (NASDAQ: NTRA), Argenx Se (NASDAQ: ARGX) and DENTSPLY SIRONA (NASDAQ: XRAY)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on NTRA
TipRanks AITipRanks
Not Ranked
TipRanks
$153
Hold
9.19%
Upside
Reiterated
07/18/25
Natera's strong financial performance and positive earnings call highlight robust revenue growth and strategic advancements in diagnostics, contributing positively to the stock score. However, technical indicators and valuation concerns, driven by a negative P/E ratio and bearish technical signals, weigh down the overall score.
Craig-Hallum Analyst forecast on NTRA
William BonelloCraig-Hallum
Craig-Hallum
Buy
Reiterated
08/04/25
Natera (NTRA) Receives a Buy from Craig-Hallum
Evercore ISI
$170
Buy
21.32%
Upside
Initiated
07/28/25
Natera (NTRA) Receives a Buy from Evercore ISIEvercore ISI analyst Daniel Markowitz initiates coverage on Natera (NASDAQ: NTRA) with a Outperform rating and a price target of $170.00.
Leerink Partners Analyst forecast on NTRA
Puneet SoudaLeerink Partners
Leerink Partners
Buy
Reiterated
07/24/25
Leerink Partners Reaffirms Their Buy Rating on Natera (NTRA)We are reiterating our confidence in NTRA (a top pick for 2Q25 earnings) in light of the continued weakness (down 7.1% in the last week and 19.1% in the last month, vs. XBI up 0.5% and the last week and up 7.2%, 5.7%, respectively, in the last month). We expect a strong beat on revenue and, more importantly, Signatera volumes to beat cons. (11.3k tests) and our 11.8k est. handily. Investor inbounds have increased with the recent sell-off and point to questions of whether NTRA will raise its OpEx guidance, and as to the emerging competitive entrants in the market. We agree that an OpEx guidance raise is likely given the priority that NTRA has to maintain its lead in the $20B (LP est) MRD market, where it's on track to deliver more than $860M+ in our model this year. Our prior conversations with the mgmt.
RBC Capital Analyst forecast on NTRA
Conor McNamaraRBC Capital
RBC Capital
$251
Buy
79.13%
Upside
Reiterated
06/30/25
RBC Capital Reaffirms Their Buy Rating on Natera (NTRA)
Barclays Analyst forecast on NTRA
Luke SergottBarclays
Barclays
$190
Buy
35.60%
Upside
Reiterated
06/25/25
Barclays Sticks to Their Buy Rating for Natera (NTRA)
Piper Sandler Analyst forecast on NTRA
David WestenbergPiper Sandler
Piper Sandler
$205$210
Buy
49.87%
Upside
Reiterated
05/15/25
Piper Sandler Sticks to Their Buy Rating for Natera (NTRA)
Morgan Stanley Analyst forecast on NTRA
Tejas SavantMorgan Stanley
Morgan Stanley
$185
Buy
32.03%
Upside
Reiterated
05/12/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (NYSE: PFE), Natera (NASDAQ: NTRA) and Regeneron (NASDAQ: REGN)
Canaccord Genuity Analyst forecast on NTRA
Kyle Mikson CFACanaccord Genuity
Canaccord Genuity
$180$195
Buy
39.17%
Upside
Reiterated
05/11/25
Natera's Strong Q1 2025 Performance and Strategic Growth Justify Buy Rating
TD Cowen
$195$200
Buy
42.73%
Upside
Reiterated
05/09/25
Natera's Strong Performance and Growth Potential Justifies Buy Rating
UBS
$211$218
Buy
55.58%
Upside
Reiterated
05/09/25
Natera price target raised to $218 from $211 at UBSNatera price target raised to $218 from $211 at UBS
BTIG
$190$195
Buy
39.17%
Upside
Reiterated
05/09/25
BTIG Reaffirms Their Buy Rating on Natera (NTRA)
Bernstein Analyst forecast on NTRA
Eve BursteinBernstein
Bernstein
$200
Buy
42.73%
Upside
Reiterated
04/15/25
Natera (NTRA) Gets a Buy from Bernstein
Robert W. Baird
$183$188
Buy
34.17%
Upside
Reiterated
02/28/25
Natera price target raised to $188 from $183 at BairdNatera price target raised to $188 from $183 at Baird
Jefferies
$195
Buy
39.17%
Upside
Reiterated
02/28/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Natera (NASDAQ: NTRA), Argenx Se (NASDAQ: ARGX) and DENTSPLY SIRONA (NASDAQ: XRAY)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Natera

1 Month
xxx
Success Rate
12/15 ratings generated profit
80%
Average Return
+9.47%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 80.00% of your transactions generating a profit, with an average return of +9.47% per trade.
3 Months
xxx
Success Rate
12/15 ratings generated profit
80%
Average Return
+17.82%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +17.82% per trade.
1 Year
Matthew SykesGoldman Sachs
Success Rate
13/15 ratings generated profit
87%
Average Return
+69.49%
reiterated a buy rating 6 months ago
Copying Matthew Sykes's trades and holding each position for 1 Year would result in 86.67% of your transactions generating a profit, with an average return of +69.49% per trade.
2 Years
xxx
Success Rate
13/15 ratings generated profit
87%
Average Return
+96.45%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 86.67% of your transactions generating a profit, with an average return of +96.45% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

NTRA Analyst Recommendation Trends

Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
3
4
4
2
1
Buy
19
17
16
16
6
Hold
3
6
5
5
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
25
27
25
23
9
In the current month, NTRA has received 7 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. NTRA average Analyst price target in the past 3 months is 201.56.
Each month's total comprises the sum of three months' worth of ratings.

NTRA Financial Forecast

NTRA Earnings Forecast

The previous quarter’s earnings for NTRA were -$0.74.
The previous quarter’s earnings for NTRA were -$0.74.

NTRA Sales Forecast

The previous quarter’s earnings for NTRA were $546.60M.
The previous quarter’s earnings for NTRA were $546.60M.

NTRA Stock Forecast FAQ

What is NTRA’s average 12-month price target, according to analysts?
Based on analyst ratings, Natera Inc.’s 12-month average price target is 201.56.
    What is NTRA’s upside potential, based on the analysts’ average price target?
    Natera Inc. has 43.85% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is NTRA a Buy, Sell or Hold?
          Natera Inc. has a consensus rating of Strong Buy which is based on 11 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Natera Inc.’s price target?
            The average price target for Natera Inc. is 201.56. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $251.00 ,the lowest forecast is $170.00. The average price target represents 43.85% Increase from the current price of $140.12.
              What do analysts say about Natera Inc.?
              Natera Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of NTRA?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis